Opus Genetics, Inc. (IRD)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $390.48M
Last updated: Nov 17, 2026 at 4:15 PM ET
Opus Genetics, Inc. (IRD) Stock Chart
Opus Genetics (IRD) has a latest price of $4.05 on Nov 17, 2026, 42.7% below its 52-week high of $7.07. Its price rose 115.4% over the past 12 months. The month-end price fell 95.4% over the 10 years through Oct 2026, a compound annual decline of 26.5%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $244.90 in Mar 2017 and its lowest $0.94 in Jun 2025, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart IRD with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for IRD.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 0.5%, and over 6 months it fell 4.9%. The month-end price rose 28.8% over the 3 years through Oct 2026, a compound annual rate of 8.8%.
| Period | Change |
|---|---|
| 1 month | +6.0% |
| 3 months | -0.5% |
| 6 months | -4.9% |
| 12 months | +115.4% |
| 12 months, with dividends | +115.4% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +28.8% | +8.8% |
| 5 years | -6.9% | -1.4% |
| 10 years | -95.4% | -26.5% |
Price by Year
Its best calendar year was 2025, when the price rose 68.9%, and its weakest was 2019, when it fell 82.9%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $3.67 | +82.6% |
| 2025 | $2.01 | +68.9% |
| 2024 | $1.19 | -60.5% |
| 2023 | $3.01 | -14.7% |
| 2022 | $3.53 | -5.4% |
| 2021 | $3.73 | -42.5% |
| 2020 | $6.49 | -15.1% |
| 2019 | $7.64 | -82.9% |
| 2018 | $44.66 | -54.0% |
| 2017 | $97.00 | +42.4% |
Trading Range
The price is 9.4% below its 50-day average of $4.47 and 5.4% below its 200-day average of $4.28.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $4.05 | |
| 52-week high | $7.07 | -42.7% |
| 52-week low | $1.80 | +125.0% |
| 50-day average | $4.47 | -9.4% |
| 200-day average | $4.28 | -5.4% |
Price Risk
Over 3 years, its largest fall from a peak was 78.3%.
| Measure | Value |
|---|---|
| 1-year beta | 1.20 |
| Largest fall, 1 year | -49.2% |
| Largest fall, 3 years | -78.3% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About IRD
What is IRD's 1-year price change?
Opus Genetics's price rose 115.4% over the past 12 months. With dividends included, the 12-month total return was 115.4%.
What is IRD's 5-year price change?
Opus Genetics's month-end price fell 6.9% over the 5 years through Oct 2026, a compound annual decline of 1.4%. These figures leave out dividends.
What is IRD's 52-week high and low?
Opus Genetics's 52-week high is $7.07 and its 52-week low is $1.80. Its latest price of $4.05 on Nov 17, 2026 is 42.7% below the high.
What is IRD's beta?
Opus Genetics's 1-year beta against the S&P 500 is 1.20, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 49.2%.
Is the IRD chart free?
Yes. Advanced Charting for IRD is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
IRD pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors